These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38841699)

  • 21. Low temperature offers better foam stability.
    Serkan M; Gokay D
    J Cosmet Dermatol; 2024 Oct; 23(10):3366-3371. PubMed ID: 38837644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
    Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
    Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
    Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Stability of Physician-Compounded Foam is Influenced by the Angle of Connector.
    Shi X; Liu Y; Li D; Tursun M; Azmoun S; Liu S
    Ann Vasc Surg; 2024 Feb; 99():217-222. PubMed ID: 37852364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of Duplex-guided polidocanol foam sclerotherapy for venous malformations.
    Ali H; Saleh M; Mohammed W
    Int Angiol; 2017 Jun; 36(3):228-236. PubMed ID: 27362577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sulodexide on stability of sclerosing foams.
    Critello CD; Fiorillo AS; Cristiano MC; de Franciscis S; Serra R
    Phlebology; 2019 Apr; 34(3):191-200. PubMed ID: 29871533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound-guided polidocanol foam sclerotherapy for treating venous malformations.
    Kumar S; Bhavana K; Kumar S; Kumar P
    J Clin Ultrasound; 2018 Jan; 46(1):23-31. PubMed ID: 29080330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foam bubble size is significantly influenced by sclerosant concentration for polidocanol but not sodium tetradecyl sulphate.
    Wong K; Connor DE; Andrade OC; Parsi K
    Phlebology; 2021 Aug; 36(7):576-587. PubMed ID: 33736561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection.
    Cavezzi A; Tessari L
    Phlebology; 2009 Dec; 24(6):247-51. PubMed ID: 19952380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injection sclerotherapy for varicose veins.
    de Ávila Oliveira R; Riera R; Vasconcelos V; Baptista-Silva JC
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD001732. PubMed ID: 34883526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foam Polidocanol Sclerotherapy for Low-Flow Vascular Malformations of Tongue.
    Mukul SK; Singh A; Kumar A; Pandey S; Singh S; Kumar A
    Ann Maxillofac Surg; 2019; 9(2):257-260. PubMed ID: 31909004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial.
    Moser KH; Mosch C; Walgenbach M; Bussen DG; Kirsch J; Joos AK; Gliem P; Sauerland S
    Int J Colorectal Dis; 2013 Oct; 28(10):1439-47. PubMed ID: 23775099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying the Most Stable State of a Foam Sclerosant for Foam Sclerotherapy.
    Zhang HS; Yang AJ; Liu S
    Dermatol Surg; 2020 Oct; 46(10):e66-e70. PubMed ID: 31895253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful Sclerotherapy for Cervicofacial Macrocystic Lymphatic Malformations Using Polidocanol and Pingyangmycin Combined Foam Sclerosants.
    Wang Q; Zhou Q; Zhao Z; Liu C; Zheng J
    Lymphat Res Biol; 2022 Oct; 20(5):507-513. PubMed ID: 35041550
    [No Abstract]   [Full Text] [Related]  

  • 35. Foam Sclerotherapy in the Treatment of Hemangiomas and Venous Malformations.
    Yang C; Li M; Li X; Zhu J; Shu C
    Dermatol Surg; 2023 Sep; 49(9):855-861. PubMed ID: 37432998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
    Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
    Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polidocanol foam stability in terms of its association with glycerin.
    Rial R; Hervas LS; Monux G; Galindo A; Martin A; Hernando M; Martinez I; Hernando A; Serrano FJ
    Phlebology; 2014 Jun; 29(5):304-9. PubMed ID: 23470491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of bleomycin polidocanol foam vs electrochemotherapy combined with polidocanol foam for treatment of venous malformations.
    Liu JW; Ni B; Gao XX; He B; Nie QQ; Fan XQ; Ye ZD; Wen JY; Liu P
    J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101697. PubMed ID: 37890588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental Study on Influence of Driving Speed on Foam Stability in Sclerotherapy for the Treatment of Varicose Veins].
    Bai T; Jiang W; Zhao W; Wan H; Fan Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Oct; 33(5):890-5. PubMed ID: 29714941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.